Evoke Pharma, Inc. Analysis
| Analyst Ratings |
|
Average Target Price
|
63.50
|
|
Average Rating
|
4.00
|
|
# Strong Buys
|
0
|
|
# Buys
|
1
|
|
# Holds
|
0
|
|
# Sells
|
0
|
|
# Strong Sells
|
0
|
| Quarterly Earnings History |
| Quarter |
EPS Estimate |
EPS Actual |
EPS Difference |
Surprise Percent |
|
2022-09-30
|
-0.66
|
-0.60
|
0.06
|
9.09%
|
|
2022-06-30
|
-0.60
|
-0.71
|
-0.11
|
-18.33%
|
|
2022-03-31
|
-0.48
|
-0.84
|
-0.36
|
-75.00%
|
|
2021-12-31
|
-0.96
|
-0.72
|
0.24
|
25.00%
|
|
2021-09-30
|
-0.84
|
-0.72
|
0.12
|
14.29%
|
|
2021-06-30
|
-0.96
|
-0.84
|
0.12
|
12.50%
|
|
2021-03-31
|
-0.78
|
-0.96
|
-0.18
|
-23.08%
|
|
2020-12-31
|
-1.62
|
-1.08
|
0.54
|
33.33%
|
| Annual Earnings History |
| Fiscal Year End |
EPS |
|
2022-12-31
|
-2.15
|
|
2021-12-31
|
-3.24
|
|
2020-12-31
|
-5.47
|
|
2019-12-31
|
-0.33
|
|
2018-12-31
|
-0.46
|
|
2017-12-31
|
-0.84
|
|
2016-12-31
|
-1.27
|
|
2015-12-31
|
-1.89
|
|
2014-12-31
|
-2.19
|
|
2013-12-31
|
-0.59
|